Profile

Michael V. Rocco, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

65 Ratings
3 Comments

Michael V. Rocco, M.D.

Professor,

Clinical Interests

Nephrology, Renal Failure, Nephrolithiasis, Kidney Disease, Clinical Nephrology, Dialysis, Hypertension

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-2097
Department: 336-716-4650

Insurance Accepted »

Education & Training

  • B.S., Seton Hall University, 1981
  • M.D., Vanderbilt University School of Medicine, 1985
  • M.S., WFU School of Medicine, 1994
  • Residency, Vanderbilt U Affil Hosps, 1988
  • Fellowship, Hosp Of The Univ Penn, 1991

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Internal Medicine, Nephrology

Memberships

  • Int'L Society Of Nephrology
  • Nat'L Kidney Foundation
  • Am Soc Of Nephrology

NPI Number

  • 1437134525
Michael V. Rocco, M.D.

Doctor Rating

4.7 out of 5

65 Ratings
3 Comments

Michael V. Rocco, M.D.

Professor, Nephrology
Public Health Sciences

Research Interests

cardiac function, drugs/therapeutic agents pharm

Contact Information

Academic: 336-716-2097 | Department: 336-716-4650

Recent Publications

Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT Jr, Sedor JR, Rocco MV, Freedman BI. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney Int. 2015;87(1):169-175.

Haller MC, van der Veer SN, Nagler EV, Tomson C, Lewington A, Hemmelgarn BR, Gallagher M, Rocco M, Obrador G, Vanholder R, Craig JC, Van Biesen W. A survey on the methodological processes and policies of renal guideline groups as a first step to harmonize renal guidelines. Nephrol Dial Transplant. 2015;30(7):1066-1074.

Mehta RL, Cerda J, Burdmann EA, Tonelli M, Garcia-Garcia G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385(9987):2616-2643.

Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS. Long-term effects of frequent nocturnal hemodialysis on mortality: the Frequent Hemodialysis Network (FHN) Nocturnal Trial. Am J Kidney Dis. 2015;():.

Fealy CE, Nieuwoudt S, Scelsi AR, Malin SK, Foucher JA, Pagadala M, Li M, Rocco M, Burguera B, Kirwan JP. High intensity crossfit exercise increases beta-cell function and insulin sensitivity in adults with type 2 diabetes [abstract]. Diabetes. 2015;64(Suppl 1):A204-A205.

Nieuwoudt S, Fealy CE, Scelsi AR, Malin SK, Foucher JA, Navaneethan SD, Li M, Rocco M, Burguera B, Kirwan JP. High intensity crossfit exercise attenuates cardiometabolic risk factors in adults with type 2 diabetes [abstract]. Diabetes. 2015;64(Suppl 1):A205.

Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI. Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant. 2014;29(3):587-594.

Hall ME, Rocco MV, Morgan TM, Hamilton CA, Edwards MS, Jordan JH, Hurie JB, Hundley WG. Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus. J Cardiovasc Magn Reson. 2014;16(1):17.

Turner KR, Fisher EC, Hade EM, Houle TT, Rocco MV. The role of perioperative sodium bicarbonate infusion affecting renal function after cardiothoracic surgery. Front Pharmacol. 2014;5():127.

Rocco M, Daugirdas J, Greene T, Lockridge R, Chan C, Pierratos A, Lindsay R, Larive B, Chertow G, Beck G, Eggers P, Kliger A, Laville M, Dorval M, Fort Ros J, Fay R, Cridlig J, Nortier JL, Juillard L, Debska-Slizien A, Fernandez Lorente L, Thibaudin D,. New dialysis techniques [abstract]. Nephrol Dial Transplant. 2014;29(Suppl 3):.

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Williamson JD, Wright JT Jr, Whelton PK. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11(5):532-546.

Kliger AS, Chertow GM, Levin NW, Beck CJ, Daugirdas JT, Eggers PW, Larive B, Rocco MV, Greene T. Long-term effects of frequent in-center hemodialysis: FHN daily trial [abstract]. Nephrol Dial Transplant. 2014;29(Suppl 3):37-38.

Kramer H, Berns JS, Choi MJ, Martin K, Rocco MV. 25-hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies report. Am J Kidney Dis. 2014;64(4):499-509.

Rocco M, Daugirdas J, Greene T, Lockridge R, Chan C, Pierratos A, Lindsay R, Larive B, Chertow G, Beck G, Eggers P, Kliger A. Mortality during extended follow-up in the frequent hemodialysis network nocturnal trial [abstract]. Nephrol Dial Transplant. 2014;29(Suppl 3):37.

Raimann JG, Chan CT, Daugirdas JT, Depner TA, Gotch FA, Green T, Kaysen GA, Kliger AS, Kotanko P, Lindsay RM, Rocco MV, Chertow GM, Levin NW. Low predialysis serum sodium modifi es the effect of hemodialysis (HD) frequency on left ventricular mass: the frequent hemodialysis network (FHN) trial [abstract]. J Am Soc Nephrol. 2014;25(Abstract Suppl):20A.

Chan CT, Rocco MV, Chertow GM, Kaysen GA, Levin NW, Larive B, Beck GJ, Kliger AS. The role of cardiomyocyte apoptosis in the pathogenesis of left ventricular hypertrophy (LVH): results from the frequent hemodialysis network (FHN) [abstract]. J Am Soc Nephrol. 2014;25(Abstract Suppl):34A-34B.

Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin D, Bild D, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT, Sedor JR, Rocco MV, Freedman BI. Association between apolipoprotein L1 gene variants with prevalent kidney and cardiovascular disease: systolic blood pressure intervention trial (SPRINT) [abstract]. J Am Soc Nephrol. 2014;25(Abstract Suppl):415A.

Chan CT, Covic A, Craig JC, Davenport A, Kasiske BL, Kuhlmann MK, Levin NW, Li PK, Locatelli F, Rocco MV, Wheeler DC. Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int. 2013;83(3):359-371.

Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, Lindsay RM, Lockridge RS, Ornt DB, Rocco MV, Ting GO, Kliger AS. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol. 2013;24(3):498-505.

Rocco MV. Does more frequent hemodialysis provide dietary freedom?. J Ren Nutr. 2013;23(3):259-262.

Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013;83(5):949-958.

Reeves-Daniel AM, Farney AC, Fletcher AJ, Assimos D, Westcott C, Rogers J, Stratta RJ, Rocco MV, Freedman BI. Ethnicity, medical insurance, and living kidney donation. Clin Transplant. 2013;27(4):E498-E503.

Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI. Gene-gene interactions in APOL1-associated nephropathy [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):67A.

Greene T, Daugirdas JT, Chertow GM, Levin NW, Rocco MV, Beck GJ, Kliger AS. Bayesian interpretation of the estimated treatment effects on mortality in the daily and nocturnal Frequent Hemodialysis Trials (FHN) [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):439A.

Daugirdas JT, Larive B, Depner TA, Pierratos A, Greene T, Lockridge RS, Ayus JC, Rocco MV, Chertow GM, Leypoldt JK, Akonur A, Miller BW. The magnitude of phosphorus mobilization during dialysis in the Frequent Hemodialysis Network (FHN) daily trial was patient-specific [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):439A.

Chertow GM, Levin NW, Back GJ, Eggers PW, Greene T, Larive B, Rocco MV, Kliger AS. Effects of randomization to frequent in-center hemodialysis on long-term mortality: Frequent Hemodialysis Daily Trial [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):442A.

Beck GJ, Chertow GM, Eggers PW, Greene T, Larive B, Levin NW, Rajagopalan S, Rocco MV, Sanz J, Tran T, Kramer C, Kliger AS. Influence of methodology on left ventricular mass measurement by cardiac magnetic resonance in the Frequent Hemodialysis Network (FHN) Nocturnal Trial [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):726A.

Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Pierratos A, Larive B, Beck GJ, Kliger AS. Effects of randomization to frequent nocturnal hemodialysis on long-term mortality: Frequent Hemodialysis Network Nocturnal Trial [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):443A.

Estrella MM, Jaar BG, Cavanaugh KL, Fox CH, Perazella MA, Soman SS, Howell E, Rocco MV, Choi MJ. Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers. BMC Nephrol. 2013;14(1):230.

Divers J, Nunez M, High KP, Murea M, Rocco MV, Ma L, Bowden DW, Hicks PJ, Spainhour M, Ornelles DA, Kleiboeker SB, Duncan K, Langefeld CD, Turner J, Freedman BI. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int. 2013;84(6):1207-1213.

Su CT, Yabes J, Pike F, Weiner DE, Beddhu S, Burrowes JD, Rocco MV, Unruh ML. Changes in anthropometry and mortality in maintenance hemodialysis patients in the HEMO Study. Am J Kidney Dis. 2013;62(6):1141-1150.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol. 2013;8(12):2106-2116.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S, Burkart J, Moossavi S, Mauck V, Kaufman T, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging. 2012;5(2):251-261.

Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM, Burkart J, Moosavi S, Mauck V, Kaufman T, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012;7(5):782-794.

Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Coppley A, et al. Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. J Nephrol. 2012;25(3):302-309.

Reeves-Daniel AM, Farney A, Fletcher A, Assimos DG, Westcott CJ, Ghanta M, Stratta RJ, Rogers J, Rocco MV, Freedman BI. Race, insurance status, and living kidney donation [abstract]. Am J Transplant. 2012;12(Suppl 3):332.

Rocco MV, Kliger AS. Benefits of frequent nocturnal home hemodialysis [reply to letter]. Kidney Int. 2012;82(1):115.

Burrowes JD, Russell GB, Unruh M, Rocco MV. Is nutritional status associated with self-reported sleep quality in the HEMO study cohort?. J Ren Nutr. 2012;22(5):461-471.

Kramer H, Berns JS, Nally J, Choi MJ, Rocco MV. A decade after the KDOQI CKD guidelines: impact on NKF-KDOQI [editorial]. Am J Kidney Dis. 2012;60(5):694-696.

Rocco MV, Berns JS. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850-886.

Freedman BI, Langefeld CD, Turner J, Nunez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int. 2012;82(7):805-811.

Freedman BI, Murea M, Rocco MV, Ma L, Bowden DW, Ornelles DA, Kleiboeker S, Langefeld CD, Turner J, Divers J. JC polyoma virus interacts with apolipoprotein L1 genetic risk in African Americans with non-diabetic nephropathy [abstract]. J Am Soc Nephrol. 2012;23():178A.

Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levine NW, Kliger AS. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. Am J Kidney Dis. 2011;57(1):90-100.

Gopalakrishnan I, Iskandar SS, Daeihagh P, Divers J, Langefeld CD, Bowden DW, Hicks PJ, Rocco MV, Freedman BI. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol. 2011;42(2):291-294.

Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis. 2011;57(1):101-112.

Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11(5):1025-1030.

Rocco MV. Nocturnal home hemodialysis: which of your patients should choose this modality? In: Ronco C, Rosner MH, eds. Hemodialysis: new methods and future technology. Basel (Switzerland): Karger;2011: 17-24.

Leung J, Dwyer J, Hibberd P, Jacques P, Rand W, Rocco MV. Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients. J Ren Nutr. 2011;21(3):246-256.

Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Graham AD, Mauck VL, Russell GB, Bleyer AJ, et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol. 2011;6(7):1635-1643.

Levin NW, Raimann JG, Rocco MV. Should the knowledge gained from the Frequent Hemodialysis Network (FHN) trials change dialysis practice?. Curr Opin Nephrol Hypertens. 2011;20(6):577-582.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Nephrology

Clinical Interests

Nephrology, Renal Failure, Nephrolithiasis, Kidney Disease, Clinical Nephrology, Dialysis, Hypertension
Michael V. Rocco, M.D.

Michael V. Rocco, M.D.

Professor, Nephrology
Public Health Sciences

Doctor Rating

4.7 out of 5

Michael V. Rocco, M.D.65 Ratings
3 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
3.9



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

2/13/2015

ALWAYS excellent care.

2/9/2015

Very good.

1/27/2015

I couldn't ask for any better. *Dr. Rocco is the greatest.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.